455 related articles for article (PubMed ID: 21274504)
1. Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.
Christensen DP; Dahllöf M; Lundh M; Rasmussen DN; Nielsen MD; Billestrup N; Grunnet LG; Mandrup-Poulsen T
Mol Med; 2011; 17(5-6):378-90. PubMed ID: 21274504
[TBL] [Abstract][Full Text] [Related]
2. Phenylbutyrate and β-cell function: contribution of histone deacetylases and ER stress inhibition.
Khan S; Komarya SK; Jena G
Epigenomics; 2017 May; 9(5):711-720. PubMed ID: 28470097
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylases in cardiovascular and metabolic diseases.
Bagchi RA; Weeks KL
J Mol Cell Cardiol; 2019 May; 130():151-159. PubMed ID: 30978343
[TBL] [Abstract][Full Text] [Related]
4. The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus.
Dewanjee S; Vallamkondu J; Kalra RS; Chakraborty P; Gangopadhyay M; Sahu R; Medala V; John A; Reddy PH; De Feo V; Kandimalla R
Cells; 2021 May; 10(6):. PubMed ID: 34071497
[TBL] [Abstract][Full Text] [Related]
5. Rationale for HDAC inhibitor therapy in autoimmunity and transplantation.
Hancock WW
Handb Exp Pharmacol; 2011; 206():103-23. PubMed ID: 21879448
[TBL] [Abstract][Full Text] [Related]
6. Exploring histone deacetylases in type 2 diabetes mellitus: pathophysiological insights and therapeutic avenues.
Kumar KK; Aburawi EH; Ljubisavljevic M; Leow MKS; Feng X; Ansari SA; Emerald BS
Clin Epigenetics; 2024 Jun; 16(1):78. PubMed ID: 38862980
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs.
Cantley MD; Haynes DR
Inflammopharmacology; 2013 Aug; 21(4):301-7. PubMed ID: 23341163
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors: Future therapeutics for insulin resistance and type 2 diabetes.
Sharma S; Taliyan R
Pharmacol Res; 2016 Nov; 113(Pt A):320-326. PubMed ID: 27620069
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia.
Ceccacci E; Minucci S
Br J Cancer; 2016 Mar; 114(6):605-11. PubMed ID: 26908329
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.
Dejligbjerg M; Grauslund M; Litman T; Collins L; Qian X; Jeffers M; Lichenstein H; Jensen PB; Sehested M
Mol Cancer; 2008 Sep; 7():70. PubMed ID: 18789133
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors as antidiabetic agents: Advances and opportunities.
Sonthalia M; Roy BS; Chandrawanshi D; Ganesh GV; Jayasuriya R; Mohandas S; Rajagopal S; Ramkumar KM
Eur J Pharmacol; 2022 Nov; 935():175328. PubMed ID: 36257383
[TBL] [Abstract][Full Text] [Related]
12. The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention.
Khan S; Jena G
Epigenomics; 2015; 7(4):669-80. PubMed ID: 26111036
[TBL] [Abstract][Full Text] [Related]
13. Role of HDAC inhibitors in diabetes mellitus.
Makkar R; Behl T; Arora S
Curr Res Transl Med; 2020 Apr; 68(2):45-50. PubMed ID: 31477543
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of histone deacetylases in melanoma-a perspective from bench to bedside.
Hornig E; Heppt MV; Graf SA; Ruzicka T; Berking C
Exp Dermatol; 2016 Nov; 25(11):831-838. PubMed ID: 27792246
[TBL] [Abstract][Full Text] [Related]
15. Function of histone deacetylase inhibitors in inflammation.
Grabiec AM; Tak PP; Reedquist KA
Crit Rev Immunol; 2011; 31(3):233-63. PubMed ID: 21740352
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors in the treatment of hematological malignancies.
Petrella A; Fontanella B; Carratù A; Bizzarro V; Rodriquez M; Parente L
Mini Rev Med Chem; 2011 Jun; 11(6):519-27. PubMed ID: 21561404
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions.
Marks PA
Biochim Biophys Acta; 2010; 1799(10-12):717-25. PubMed ID: 20594930
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics.
Meier BC; Wagner BK
Epigenomics; 2014 Apr; 6(2):209-14. PubMed ID: 24811789
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylases 1 and 2 inhibition suppresses cytokine production and osteoclast bone resorption in vitro.
Algate K; Haynes D; Fitzsimmons T; Romeo O; Wagner F; Holson E; Reid R; Fairlie D; Bartold P; Cantley M
J Cell Biochem; 2020 Jan; 121(1):244-258. PubMed ID: 31222845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]